Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer (Q45770152)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 November 2011

Language	Label	Description	Also known as
English	Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer	scientific article published on 15 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

11

object named as

Yung-Jue Bang

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

author name string

June Koo Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Heae Surng Park

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Dong-Wan Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Kimary Kulig

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Tae Min Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Se-Hoon Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Yoon-Kyung Jeon

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Doo Hyun Chung

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Dae Seog Heo

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Woo-Ho Kim

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

language of work or name

0 references

publication date

15 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

118

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

14

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

3579-3586

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

Lung cancer: New biological insights and recent therapeutic advances

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

New driver mutations in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

EML4-ALK: honing in on a new target in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

A mouse model for EML4-ALK-positive lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Cancer. Addiction to oncogenes--the Achilles heal of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

The biology and treatment of EML4-ALK non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease? Evaluation of Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363(18):1693-703.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Targeting anaplastic lymphoma kinase in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

21 January 2018

Finding ALK-positive lung cancer: what are we really looking for?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26668

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.26668

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22086654

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45770152&oldid=2184762892"